By Evan Lee Salim 
The landscape of venture capital in the United States remains firmly in the grip of the artificial intelligence revolution. As we move through the mid-year mark of 2026, the data from the past week serves as a stark reminder that while the broader market navigates economic uncertainty, capital is flowing with unprecedented velocity toward the companies building the foundational infrastructure of the next technological era.
For the week of June 18–26, the U.S. startup ecosystem saw a flurry of activity, headlined by a staggering $1.5 billion Series F round for Baseten. This massive injection of capital into AI inference technology underscores a broader shift: the industry is moving past the "hype" phase of large language models and into the "industrialization" phase, where companies are focused on the hardware, software, and infrastructure required to actually run these complex workloads at scale.
The Weekly Megadeals: A Breakdown of the Top 10
The following list represents the largest announced funding rounds for U.S.-based companies during this period.
1. Baseten ($1.5 Billion)
San Francisco-based Baseten has solidified its position as a pillar of the AI ecosystem by raising $1.5 billion in Series F funding. This marks the company’s fourth major fundraise in just 18 months, a testament to the insatiable demand for systems software that can handle AI application workloads. The round, co-led by Altimeter Capital, Conviction Partners, Spark Capital, Sands Capital, and Wellington Management, values the company at an impressive $13 billion.
2. AppsFlyer ($1 Billion)
In the digital marketing sphere, AppsFlyer secured a massive $1 billion Series E. With a post-money valuation of $2.7 billion, the San Francisco firm is leveraging its deep data analytics capabilities to reshape how companies measure marketing performance. Notably, the round attracted strategic backing from industry titans including Meta, Google, Unity, and Moloco.
3. Groq ($650 Million)
Despite a tumultuous six months that included a high-profile "acquihire" event by Nvidia, Groq has bounced back with a $650 million funding round. Led by Infinitum and Disruptive, the capital is earmarked to scale its specialized AI inference cloud technology, proving that the market remains bullish on hardware-software co-design.
4. Ollin Biosciences ($330 Million)
Breaking the AI monotony, Austin-based Ollin Biosciences secured $330 million in Series B funding. The company, which focuses on ophthalmic therapies for vision-threatening diseases, saw participation from top-tier biotech investors TCG Crossover and Arch Venture Partners.
5. General Intuition ($320 Million)
General Intuition is pushing the boundaries of "foundational AI" by developing models rooted in game theory and gameplay. The New York-based startup raised $320 million in Series A funding at a $2.3 billion valuation, with Khosla Ventures leading the charge and support from high-profile backers like Jeff Bezos and General Catalyst.
6. Peregrine Technologies ($250 Million)
Government tech remains a resilient sector. Peregrine Technologies, which provides critical data platforms for public safety agencies, secured $250 million in Series D financing. The round sets the company’s valuation at $6.8 billion, backed by a consortium including Sequoia Capital and Fifth Down Capital.
7. Quantifind and Mirendil ($200 Million Each)
In a tie for seventh place, we see two distinct applications of intelligence. Quantifind (Palo Alto) is leveraging its risk intelligence platform to fight financial crime, while Mirendil (San Francisco) is positioning itself as a frontier lab for AI R&D. Mirendil’s $200 million seed round is particularly notable for having Andreessen Horowitz and Kleiner Perkins as lead investors.
9. Upscale AI and Osanni Bio ($190 Million Each)
Rounding out the top ten, Upscale AI added $190 million to its coffers for AI networking infrastructure, reaching a $2 billion valuation. Simultaneously, Osanni Bio secured $190 million in Series B funding to advance its work in therapeutic platforms.
The Chronology of Capital: Why Now?
The timing of these deals is not incidental. As we approach the end of the second quarter of 2026, venture firms are under significant pressure to deploy capital before the fiscal year-end reports. Furthermore, the stabilization of interest rates—relative to the volatility seen in 2024 and 2025—has encouraged investors to return to growth-stage investing.
The week began with a flurry of biotech announcements, signaling that while AI grabs the headlines, the "life sciences" sector remains a critical defensive play for institutional investors. By mid-week, the focus shifted sharply back to AI infrastructure, as Baseten and Groq finalized their massive rounds, effectively creating a "liquidity wave" that pushed the total weekly capital influx well into the multi-billion-dollar range.
Supporting Data: The Shift in Sector Concentration
When we analyze the sector breakdown of the top 10 deals, the narrative is clear:
- AI Infrastructure & Foundational Models: 60% of the top 10.
- Biotech/Ophthalmic Therapeutics: 20% of the top 10.
- Government/Risk Tech: 20% of the top 10.
This concentration indicates that investors are betting on the "picks and shovels" of the AI revolution. Rather than funding every consumer-facing AI wrapper, capital is being funneled into companies that solve the underlying bottlenecks of AI—specifically latency (Groq), infrastructure (Upscale AI), and deployment software (Baseten).
Official Responses and Investor Sentiment
The sentiment from lead investors suggests a "flight to quality." In statements regarding the Baseten round, representatives from Altimeter Capital emphasized that "the era of experimentation is over; we are now in the era of deployment." This sentiment is mirrored across the board.
Investors like those at Sequoia Capital and Andreessen Horowitz have recently signaled that they are less interested in "AI-enabled" businesses and are instead hunting for "AI-native" companies—those that could not exist without the recent breakthroughs in machine learning. The $200 million seed round for Mirendil, in particular, signals a willingness to bet massive amounts of capital on unproven, but high-potential, frontier research teams.
Implications: The Road Ahead for 2026
What does this surge mean for the broader economy?
1. Valuation Inflation
The valuation of $13 billion for Baseten and $6.8 billion for Peregrine Technologies raises questions about the long-term sustainability of current market prices. While these companies are generating significant revenue, the disconnect between traditional SaaS multiples and current AI-infrastructure valuations is widening.
2. The Consolidation Risk
With giants like Nvidia, Google, and Meta participating in these rounds, we are seeing the rise of "ecosystem-led" venture capital. These companies are not just investors; they are future potential acquirers. This suggests a future landscape where the startup ecosystem is increasingly tethered to the strategic needs of the "Big Tech" players.
3. The "AI-Only" Funding Gap
While the top 10 list is robust, it hides a growing divide. Startups that do not have a clear, AI-centric value proposition are finding it increasingly difficult to raise large-scale venture capital. We are entering a two-tier market: those who are riding the AI wave, and those who are struggling to find liquidity in a capital-constrained environment.
4. International Competitiveness
The inclusion of large European deals—such as the $569 million raised by Berlin’s Stark and the $546 million raised by Paris-based Alan—demonstrates that the AI race is global. U.S. startups are currently leading in terms of absolute dollars, but the European tech scene is rapidly professionalizing its funding structures to compete.
Conclusion
The funding data from the third week of June 2026 confirms that we are living through a unique chapter in venture capital history. The influx of $4.5 billion into these top 10 firms is not merely a sign of optimism; it is a calculated investment in the infrastructure of the future. As these companies use their newfound capital to scale, the industry will be watching closely to see which of these bets turn into the next generation of public market leaders and which succumb to the inherent risks of the high-stakes AI game.
For founders, the message is clear: if you are building in the infrastructure, biotech, or government-tech space, the capital is there. For everyone else, the bar for entry has never been higher.
Azzam Bilal Chamdy 
Suro Senen 
Neng Nana 